| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Steri-Source is a Burley, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
National Dentex Corporation is a network of local dental labratories providing the competitive pricing and resources of a large laboratory along with the personalized support of a local lab. NDX has more than 40 locations across the United States and Canada.
Kankakee County Health Department is a Kankakee, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
e+CancerCare is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.